Psychometric evaluation of the COPD assessment test: Data from the BREATHE study in the Middle East and North Africa region
Authors:
- Naem ShahrourNSNaem Shahrour
- Chakib NejjariCNChakib Nejjari
- Aicha LahlouALAicha Lahlou
- Adam DobleADAdam Doble
- Nauman RashidNRNauman Rashid
- Abdelkader El HasnaouiAHAbdelkader El Hasnaoui
- 1 December 2012
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 106, S86-S99
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE studyRespiratory Medicine, 2012
- Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sampleCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2012
- Properties of the COPD assessment test in a cross-sectional European studyEuropean Respiratory Journal, 2011
- Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary diseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 2011
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Multinational Trials—Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force ReportValue in Health, 2009
- Validation of a Chronic Obstructive Pulmonary Disease screening questionnaire for population surveysRespiratory Medicine, 2004
- Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International SurveyEuropean Respiratory Journal, 2002
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992
- A measure of quality of life for clinical trials in chronic lung disease.Thorax, 1987